GeoVax Labs, Inc. financial data

Symbol
GOVX on Nasdaq
Location
Smyrna, GA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 290% % 81%
Return On Equity -490% % 40%
Return On Assets -326% % 6.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29,705,360 shares 215%
Common Stock, Shares, Outstanding 29,705,360 shares 245%
Entity Public Float $13,192,305 USD -8.2%
Common Stock, Value, Issued $29,705 USD 245%
Weighted Average Number of Shares Outstanding, Basic 20,287,203 shares 217%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $22,735,212 USD 1.8%
General and Administrative Expense $6,160,041 USD 17%
Operating Income (Loss) $25,541,693 USD -4.3%
Nonoperating Income (Expense) $54,301 USD 39%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $25,309,002 USD -4.1%
Earnings Per Share, Basic 0 USD/shares 94%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,008,997 USD -42%
Accounts Receivable, after Allowance for Credit Loss, Current $0 USD -100%
Assets, Current $6,517,248 USD -40%
Property, Plant and Equipment, Net $127,060 USD -26%
Other Assets, Noncurrent $86,947 USD 22%
Assets $6,731,255 USD -39%
Accounts Payable, Current $976,411 USD -55%
Accrued Liabilities, Current $847,766 USD 84%
Liabilities, Current $1,824,177 USD -30%
Retained Earnings (Accumulated Deficit) $146,402,429 USD -21%
Stockholders' Equity Attributable to Parent $4,907,078 USD -42%
Liabilities and Equity $6,731,255 USD -39%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $5,965,680 USD -5%
Net Cash Provided by (Used in) Financing Activities $7,914,402 USD
Net Cash Provided by (Used in) Investing Activities $16,894 USD
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 29,705,360 shares 245%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,931,828 USD
Deferred Tax Assets, Valuation Allowance $36,783,772 USD 23%
Deferred Tax Assets, Gross $36,813,584 USD 23%
Payments to Acquire Property, Plant, and Equipment $16,894 USD
Property, Plant and Equipment, Gross $938,628 USD 3%
Deferred Tax Assets, Operating Loss Carryforwards $30,374,640 USD 19%
Depreciation, Depletion and Amortization $16,921 USD -14%